SEC Filings/Listing & compliance
Nasdaq Deficiency Notices in 2026: Who Got One, and Who Cured
Nasdaq deficiency notices disclosed in 2026 by listing rule, with dated outcomes: compliance regained, delisted or moved to OTC, still in the compliance period.
Look up any company's filings, insider trades and dilution on Signal8.
Key takeaways
- From January 1 to November 16, 2026, 405 companies disclosed at least one Nasdaq deficiency notice, and 278 of them were for the $1.00 minimum bid price.
- Of the 99 companies first notified of a bid price deficiency in Q1 2026, 25 later filed that they had regained bid price compliance by November 16.
- In the same Q1 group, 7 were delisted or moved to OTC trading, 15 were still in a compliance period, and 43 had no measured outcome.
- 96 of the 278 bid price companies completed a reverse split after their first 2026 notice.
- An outcome that was not found is counted as not measured, never as a failure to cure.
The short version
Signal8's count: from January 1 to November 16, 2026, 405 companies disclosed at least one Nasdaq deficiency notice, in 581 filings. 278 were told they had fallen below the $1.00 minimum bid price, by far the most common deficiency. Another 91 companies disclosed a later step in the delisting process, such as a Staff delisting determination, a hearing panel decision or a trading suspension.
Most 2026 notices do not have an outcome yet: a bid price notice comes with 180 calendar days to cure, and some companies get a second 180. The cleanest view is the first quarter. Of the 99 companies first notified of a bid price deficiency in Q1 2026, by November 16: 25 filed that they had regained bid price compliance, 7 were delisted or moved to OTC trading, 15 were still inside a compliance period, and 43 had no outcome Signal8 could measure.
How the notice process works, rule by rule, is in Nasdaq deficiency notices. This page counts what happened in 2026.
Notices by listing rule, 2026
One row per company and standard, counted from the company's first 2026 notice under that standard. Filings are the 8-Ks and 6-Ks reporting a notice, so a company that disclosed the same matter twice adds two filings and one company. Outcomes are as of November 16, 2026.
| Standard (Nasdaq rule cited) | Companies | Filings | Regained, same standard | Regained, standard not matched | Delisted or OTC | Compliance period running | Not measured |
|---|---|---|---|---|---|---|---|
| Minimum bid price (5550(a)(2), 5450(a)(1)) | 278 | 334 | 39 | 27 | 19 | 131 | 62 |
| Equity, market value of listed securities or net income (5550(b), 5450(b)) | 100 | 115 | 13 | 20 | 9 | 8 | 50 |
| Late periodic report (5250(c)(1)) | 33 | 58 | 1 | 8 | 3 | 0 | 21 |
| Audit committee or board independence (5605) | 24 | 25 | 3 | 2 | 1 | 0 | 18 |
| Public float, publicly held shares or holders | 12 | 18 | 0 | 2 | 1 | 0 | 9 |
| Annual meeting (5620(a)) | 4 | 4 | 0 | 2 | 0 | 0 | 2 |
| Other rules, or no rule stated | 25 | 27 | 0 | 0 | 4 | 0 | 21 |
A company can appear in more than one row. "Regained, same standard" means a later filing by the company said it had regained compliance with that standard. "Standard not matched" means a later filing said the company regained compliance with something, but Signal8 could not tie it to this standard; it is shown separately rather than counted as a cure. "Compliance period running" uses the deadline the company stated, or 180 days from the notice where it stated none.
Late filing, board and annual meeting notices work differently: the company submits a plan and Nasdaq can grant time, so there is no fixed period to count down, and most of their outcomes fall into "not measured".
Bid price notices by quarter
The bid price rule, Rule 5810(c)(3)(A), gives 180 calendar days from the notice to close at $1.00 or more for at least 10 consecutive business days. Grouping companies by the quarter of their first 2026 bid price notice shows how far each group has run:
| First notice | Companies | Regained bid price | Regained, standard not matched | Delisted or OTC | Period running | Not measured |
|---|---|---|---|---|---|---|
| 2026 Q1 | 99 | 25 | 9 | 7 | 15 | 43 |
| 2026 Q2 | 62 | 11 | 9 | 6 | 17 | 19 |
| 2026 Q3 | 56 | 1 | 9 | 6 | 40 | 0 |
| 2026 Q4 (to Nov 16) | 61 | 2 | 0 | 0 | 59 | 0 |
The Q3 and Q4 groups are mostly still inside their first 180 days, so their outcomes will change. A Q1 company still "running" was granted, or stated, a second compliance period that ends after November 16.
The reverse split route
96 of the 278 bid price companies completed a reverse split between their first 2026 notice and November 16. Among the 39 that later filed a bid price cure, 24 had reverse split; among the 62 with no measured outcome, 32 had. Separately, 82 companies filed a bid price compliance-regained notice in 2026 (some for notices received in late 2025), and 30 of them had a reverse split take effect in the 60 days before that filing.
A reverse split can cure a bid price deficiency, but not every time: since January 2025, a company that falls below $1.00 within a year of a reverse split gets no compliance period at all (the one-year rule). The live list of scheduled splits is the reverse split calendar guide.
Companies notified under three standards
Three companies disclosed 2026 Nasdaq notices under three different continued listing standards. Each notice below was checked against the company's own 8-K on EDGAR on November 17, 2026.
| Company | 2026 notices disclosed | Status found by Nov 16, 2026 |
|---|---|---|
| Borealis Foods Inc. (BRLS) | Annual meeting, 5620(a) (Jan 16); late periodic report, 5250(c)(1) (Apr 23, Sep 1); market value of listed securities, 5550(b)(2) (Jul 8) | Its Nov 4 8-K said it believed it had regained compliance with the audit committee rule; no matched cure for the three standards listed |
| Triller Group Inc. (ILLR) | Late periodic report, 5250(c)(1) (Mar 30); bid price, 5550(a)(2), a hearing panel exception to July 30, 2026 (Jul 15); market value of listed securities, 5550(b)(2) (Sep 2) | Signal8 records its shares as suspended to OTC trading from October 7, 2026; EDGAR lists them as OTC |
| SolarMax Technology, Inc. (SMXT) | Bid price, 5550(a)(2) (Mar 10); market value of listed securities, 5550(b)(2) (Jun 30); late periodic report, 5250(c)(1) for its June 30 10-Q (Aug 21) | No outcome measured |
A deficiency notice is a statement that a listing standard is not met. It says nothing about the company's business beyond that.
Method and exclusions
- Source: Signal8's deficiency notice table, built from 8-K Item 3.01 filings and 6-Ks found by SEC full-text search, with the full text read for the rule cited. Filings dated January 1 to November 16, 2026, on Nasdaq. NYSE and NYSE American notices are excluded here.
- Notice type follows the cited rule. On November 17, 2026 Signal8 re-typed its stored notices by the rule each one cites rather than by keywords, which changed 166 of 932 rows; the counts above are after that change. A notice that cites two open matters is counted under the first rule it states.
- Not a notice: filings that report only that compliance was regained (154 filings by 128 companies in 2026) are counted as cures, not as new notices.
- Cures: a later filing saying the company regained compliance. Some such filings are not matched to a specific standard; those are reported in their own column.
- Delisted or OTC: Signal8's listing-state record shows the ticker suspended to OTC or delisted after the first notice. 25 company-standard rows have no ticker and cannot be matched here.
- Not measured: no cure filing, no delisting record and no running deadline was found. That can mean an appeal, a plan still under review, a cure announced only in a press release, or a filing Signal8 missed. It is never counted as "not cured".
FAQ
How many companies got a Nasdaq deficiency notice in 2026?
405 companies disclosed at least one from January 1 to November 16, 2026, and 278 of those notices were for the $1.00 minimum bid price. Another 91 companies disclosed a later delisting step.
How many companies cure a Nasdaq bid price deficiency?
Of the 99 companies first notified in Q1 2026, 25 filed that they had regained bid price compliance by November 16, and 9 more filed a compliance notice not matched to the bid price. Seven were delisted or moved to OTC, and 15 were still inside a compliance period.
Where can I see current deficiency notices?
The Delist Watch scanner lists companies with an open notice or another listing flag, and recently delisted stocks lists those that have left an exchange. The forms behind a delisting are explained in Form 25 vs Form 15.
Terms in this guide
- Deficiency notice
- A deficiency notice is an exchange letter telling a listed company it no longer meets a continued listing requirement, such as the $1.00 minimum bid price, and starts a compliance period.
- Form 8-K
- A Form 8-K is the SEC current report a public company files, generally within four business days, to disclose material events such as agreements, offerings, executive changes and listing notices.
- Form 25
- Form 25 is the SEC form filed to remove a class of securities from listing on a national securities exchange; the delisting takes effect 10 days after it is filed.
- Reverse stock split
- A reverse stock split is a corporate action combining existing shares into fewer shares, cutting the share count and raising the per-share price by the same ratio; ownership percentages stay the same.
Try it on Signal8
See this in live data with Nasdaq delisting list.
Related guides
All SEC Filings guidesSEC Filings
Nasdaq Delisting Notices and the $1 Bid Price Rule
Nasdaq delisting notices (deficiency notices) explained: the $1 bid price rule, its 180-day periods, other standards, the 2025 reverse split limits.
7 min read
SEC Filings
Nasdaq's One-Year Reverse Split Rule: Who Gets No Grace Period Below $1
Nasdaq's one-year reverse split rule explained, with a dated list of Nasdaq companies that reverse split in the last 12 months and closed below $1.00.
7 min read
SEC Filings
Nasdaq's $5 Million Market Value Rule: What It Says and How Many Companies Are Below It
Nasdaq's $5 million market value of listed securities rule: what it requires, why it is stayed, and a dated count of Nasdaq companies below $5 million.
6 min read
SEC Filings
Form 25 vs Form 15: Delisting vs Deregistration
Form 25 vs Form 15 explained: how delisting removes a stock from an exchange, how deregistration ends SEC reporting, who files each and the timelines.
6 min read
SEC Filings
NT 10-K and NT 10-Q Late Filing Notices Explained
NT 10-K and NT 10-Q explained: the Rule 12b-25 extension of 15 or 5 days, what the notice must disclose, and what happens if the report is still late.
6 min read
SEC Filings
What Time Do SEC Filings Come Out? 8-K Filing Times by Hour and Day
When 8-Ks, 6-Ks, offerings and Form 4s reach EDGAR: filing times by hour and weekday, the 4 p.m. rush, Friday Item 3.01 notices and holiday eves.
6 min read
SEC Filings
Form 8-K Explained: Item Codes 1.01 to 9.01
Form 8-K explained: what the current report is, what Items 1.01, 2.03, 3.01, 3.02, 5.02 and 9.01 mean, the four-business-day rule and financing item pairs.
6 min read
Educational content only. Signal8 is not a broker-dealer or investment adviser, and nothing here is a recommendation to buy or sell any security.